Granted Patent B2

US 12,521,574 · App. 17/297,145 · Granted Jan 13, 2026

Inventors: Charles D. Emery (Gilbert, AZ); Wohsing P. Chen (Chandler, AZ); Robert B. A. Adamson (Halifax, CA); Peeter Hugo Vihvelin (Sambro Creek, CA); Daniel Zaenker (Halifax, CA); Nicholas A. Campbell (Halifax, CA); Matthew A. Wright (Halifax, CA); Jeffrey R. Leadbetter (Halifax, CA); Jeremy A. Brown (Halifax, CA)

Assignee: Ulthera, Inc.

A61N7/02H03F3/193H03F3/2173A61N2007/0095B06B1/0207B06B1/0644B06B2201/76H03F1/565

Abstract

Claims (60)

1 . An ultrasound treatment system comprising:

an ultrasonic probe comprising an ultrasound therapy transducer adapted to apply ultrasonic therapy to tissue;

an electrical power system configured to provide electrical power to the ultrasound therapy transducer, the electrical power system comprising a power amplifier device;

wherein the power amplifier device comprises:

a switch-mode amplifier circuit configured to generate digital waveforms to drive semiconductor transistors configured in an H-bridge configuration to drive the ultrasound therapy transducer;

a comparator circuit to generate an H-bridge drive signal for modulation of a gate of each semiconductor transistor configured in the H-bridge configuration,

wherein the semiconductor transistors are field effect transistors,

configured to operate with an efficiency of at least 75% at a radio frequency (RF) in a range between 200 kHz and 20 MHz; and

wherein the H-bridge drive signal driving the field effect transistors is generated by the comparator circuit comparing an output of a sinusoidal direct digital synthesis circuit to a DC voltage wherein an output power is in the range from 0.1 W to 100 W.

2 . The ultrasound treatment system of claim 1 ,

wherein the comparator circuit configured to generate digital waveforms to drive the semiconductor transistors to drive the ultrasound therapy transducer.

3 . The ultrasound treatment system of claim 1 ,

wherein the switch-mode amplifier circuit comprises four semiconductor transistors configured in the H-bridge configuration.

4 . The ultrasound treatment system of claim 1 ,

wherein the semiconductor transistors are gallium nitride,

wherein power amplifier device comprises:

the switch-mode amplifier circuit comprising at least one gallium nitride field effect transistor, wherein each gallium nitride field effect transistor comprises at least one gate; and

the comparator circuit configured to generate digital waveforms to drive the at least one gate of the at least one gallium nitride field effect transistors to drive a piezoelectric ultrasound transducer;

wherein the comparator circuit comprises four gallium nitride transistors configured in the H-bridge configuration;

wherein a gate drive signal has a variable duty cycle that is used to control a harmonic content and a power in the output signal;

wherein a power amplifier converter supplies power to a radio frequency output signal power with an efficiency greater than 75%;

wherein a supply voltage to the power amplifier device is modulated using a switch-mode DC-DC converter that reduces a fixed high voltage input to a lower supply voltage;

a power amplifier is configured to drive at a single piezoelectric transduction element of a high-intensity focused ultrasound transducer;

wherein the power amplifier is configured to drive the output signal at two or more different amplitudes;

wherein the power amplifier is configured to drive the output signal at two or more different phases;

wherein a phase and a frequency are controlled by a direct digital synthesizer;

wherein the system is configured to drive transducers with an impedance in the range from 20 ohms to 120 ohms and a phase angle from +45 degrees to −45 degrees.

5 . The ultrasound treatment system of claim 1 , wherein the semiconductor transistors comprise Gallium Nitride (GaN).

6 . The ultrasound treatment system of claim 1 , wherein the semiconductor transistors comprise a III-V compound.

7 . An ultrasound treatment system comprising:

an ultrasonic probe comprising an ultrasound therapy transducer adapted to apply ultrasonic therapy to tissue; and

an electrical power system configured to provide electrical power to the ultrasound therapy transducer, the electrical power system comprising a power amplifier device;

wherein the power amplifier device comprises:

a switch-mode amplifier circuit configured to generate digital waveforms to drive semiconductor transistors configured in an H-bridge configuration to drive the ultrasound therapy transducer; and

a comparator circuit to generate an H-bridge drive signal for modulation of a gate of each semiconductor transistor configured in the H-bridge configuration,

wherein the semiconductor transistors are configured to operate with an efficiency of at least 50% at a radio frequency (RF) in a range between 1.0 MHz and 12.0 MHz,

wherein the H-bridge drive signal driving the semiconductor transistors are generated by comparing an output of a sinusoidal direct digital synthesis circuit to a DC voltage.

8 . The system of claim 7 , wherein power amplifier device comprises:

the comparator circuit configured to generate digital waveforms to drive the semiconductor transistors to drive a piezoelectric ultrasound transducer.

9 . The ultrasound treatment system of claim 7 , wherein an output power is in the range from 0.1 W to 100 W, and wherein the circuit comprises four power transistors configured in an H-bridge configuration.

10 . The ultrasound treatment system of claim 7 , wherein a power amplifier converter supplies power to a radio frequency output signal power with an efficiency greater than 90%.

11 . The ultrasound treatment system of claim 7 , comprising two or more power amplifiers, wherein a single power amplifier is configured to drive a single piezoelectric transduction element of a high-intensity focused ultrasound transducer.

12 . The ultrasound treatment system of claim 7 , wherein the power amplifier is configured to drive output at two or more different amplitudes.

13 . The ultrasound treatment system of claim 7 , wherein the power amplifier is configured to drive output at two or more different phases.

14 . An ultrasound treatment system comprising:

an ultrasonic probe comprising a housing containing a piezoelectrically active ultrasound therapy transducer adapted to focus acoustic ultrasonic waves a depth from the housing in a focal zone in a tissue;

an electrical power system configured to provide electrical power to the ultrasound therapy transducer, the electrical power system comprising a power amplifier, wherein a signal driving at least one semiconductor transistor of the power amplifier is generated by comparing an output of a sinusoidal direct digital synthesis circuit to a DC voltage; and

an electrical power measurement system configured to monitor electrical output power from an output signal from the power amplifier,

wherein the power amplifier comprises:

a switch-mode amplifier circuit configured to generate digital waveforms to drive the at least one semiconductor transistor configured in an H-bridge configuration to drive the ultrasound therapy transducer;

a comparator circuit to generate an H-bridge drive signal for modulation of a gate of the at least one semiconductor transistor configured in the H-bridge configuration,

wherein the electrical power measurement system comprises:

a resistive current sensing circuit configured to monitor an electrical current output from the power amplifier; and

a resistive voltage sensing circuit configured to monitor an electrical voltage output from the power amplifier, and

wherein the electrical power measurement system is configured to monitor electrical output power from the power amplifier in a frequency range spanning at least two octaves for the ultrasound therapy transducer.

15 . The ultrasound treatment system of claim 14 , wherein the measurement system is configured to take multiple measurements at different relative phase shifts between the local oscillator and the power amplifier.

16 . The ultrasound treatment system of claim 14 , wherein the local oscillator clock is generated from an independently controlled direct digital synthesizer.

17 . The ultrasound treatment system of claim 14 , wherein the number of phase measurements is six.

18 . The ultrasound treatment system of claim 14 , wherein the measurement system is configured to take multiple measurements at local oscillator frequencies.

19 . The ultrasound treatment system of claim 14 , configured to modify a gate drive signal so as to achieve a desired harmonic content in the output signal.

Assignments (2)

Continuity (2)

References Cited (400)